Status:
UNKNOWN
Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section
Lead Sponsor:
Assiut University
Collaborating Sponsors:
Yasser Esmat Mohammed
Conditions:
Emergency Cesarean Section
Infection Wound
Eligibility:
FEMALE
20-40 years
Phase:
PHASE2
PHASE3
Brief Summary
Compare between cefepime versus routine antibiotics as a prophylactic antibiotic during emergency cesarean section in a tertiary center of obstetric care
Detailed Description
This is a randomized double blinded study which compare between single dose cefepime versus cefuroxime plus metronidazole during emergency intrapartum cesarean section. Outcomes will include fever, w...
Eligibility Criteria
Inclusion
- intrapartum caesarean section
Exclusion
- evidence of infection
Key Trial Info
Start Date :
July 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04009772
Start Date
July 1 2019
End Date
March 1 2020
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt, 71515